REFEX270.90

Refex Industries Ltd.

· Chemicals
₹ CrorePeersRCFRALLISRAINPRIVISCLSHARDACROPNFLSTYRENIXNEOGENMcap ₹3,717 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)9.574.9814.4714.47
Receivable Days (DSO)80.75100.10142.08142.08
Payable Days (DPO)71.89115.2988.3085.88
Cash Conversion Cycle (days)18.43-10.2168.2570.67
Working Capital Turnover4.492.501.882.36
Asset Turnover1.731.370.800.80
Cash Conversion (CFO/Net Income)0.03-1.670.530.53
CFO/EBITDA0.02-1.260.300.30
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.